NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/30/2025
Back to search
Official data from USPTO
PABEFA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
05/31/2025
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
10/08/2019
Registration date
05/05/2020
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/05/2020
Last transaction
05/31/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
GB
Examiner
BAKER,JORDAN A
Law office
O30
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Glaxo Group Limited
Representatives
Legal Brand Protection, GlaxoSmithKline
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseasesblood disorderspaininflammationsepsisalopeciaobesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viralmetabolicendocrinemusculoskeletalcardiovascularcardiopulmonarygenitourinarysexual dysfunctiononcologicalhepatologicalophthalmicrespiratoryneurologicalgastrointestinalhormonaldermatologicalpsychiatric and immune system related diseases and disorders; vaccines
Publications
History of USPTO decisions and trademark events.
16 publications found
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
08/11/2023
GPNX
NOTIFICATION PROCESSED BY IB
07/24/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/08/2020
FIMP
FINAL DISPOSITION PROCESSED
07/08/2020
GPAR
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
06/04/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
05/05/2020
PUBO
PUBLISHED FOR OPPOSITION
02/18/2020
NPUB
NOTICE OF PUBLICATION
01/29/2020
ALIE
ASSIGNED TO LIE
01/14/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/13/2020
DOCK
ASSIGNED TO EXAMINER
01/13/2020
MAFR
APPLICATION FILING RECEIPT MAILED
12/21/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/17/2019
LIMI
LIMITATION FROM ORIGINAL APPLICATION ENTERED
12/16/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/05/2019
Continuous trademark protection
Get notified about every new filing that threatens PABEFA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.